Title: Federal Government Shuts Down Research on Human Subjects at New York State Psychiatric Institute Following Tragic Suicide
In a tragic turn of events, the federal government has decided to halt all research involving human subjects at the New York State Psychiatric Institute. This decision was made following the suicide of a participant involved in a study conducted by Dr. Bret Rutherford, a renowned researcher and leader of the institute.
The Department of Health and Human Services’ Office for Human Research Protections is currently conducting a comprehensive investigation into the safety protocols at the institute. As a result of this ongoing investigation, several restrictions have been imposed on the institute’s ability to conduct any further research involving human subjects that is supported by the HHS.
Dr. Rutherford, who was leading the study investigating the use of levodopa, a Parkinson’s disease drug, to treat depression and reduced mobility in older individuals, has tendered his resignation from the institute and Columbia University following this tragic incident. It is worth noting that Dr. Rutherford had received grants totaling over $15.5 million from the National Institutes of Health since 2010, highlighting the significance and scope of his research.
While the institute’s spokesperson has refrained from confirming the death of the participant, they did highlight that necessary changes have been made to the research protocols. It was disclosed that the research involving human subjects was suspended in early June, according to the institute.
Dr. Rutherford enrolled a total of 51 individuals aged 60 and older in his study, with the aim of exploring whether levodopa could alleviate depression in the late stages of life. However, the group was later reduced to 31 participants.
In response to this unfortunate incident, the New York state’s Office of Mental Health, which oversees the institute, is actively seeking federal approval for a new research safety plan. This plan intends to establish stringent safety measures and protocols to allow federally funded studies to resume at the institute.
The tragic death of a participant has undoubtedly raised concerns about the safety and ethical considerations surrounding research involving human subjects. It is hoped that the investigation being conducted by the Office for Human Research Protections will shed light on any shortcomings in the institute’s safety protocols, and that effective measures will be implemented to prevent such incidents in the future.
As stakeholders await the findings of the ongoing investigation, it is imperative that the safety, well-being, and dignity of human subjects remain at the forefront of all research endeavors. The New York State Psychiatric Institute and research institutions worldwide must work together to ensure rigorous safety standards, transparent protocols, and stringent oversight to protect participants and advance scientific knowledge responsibly.
“Devoted bacon guru. Award-winning explorer. Internet junkie. Web lover.”
